Cronos Group Inc. (CRON)
$
2.56
+0.04 (1.56%)
Key metrics
Financial statements
Free cash flow per share
0.0003
Market cap
991.5 Million
Price to sales ratio
6.7174
Debt to equity
0.0025
Current ratio
19.5921
Income quality
-6.0868
Average inventory
47.4 Million
ROE
-0.0087
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cronos Group Inc. operates as a cannabinoid company, engaged in the manufacture, marketing, and distribution of hemp-derived supplements and cosmetic products under the Lord Jones and Happy Dance brands through e-commerce, retail, and hospitality partners in the United States. The company is also active in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for both medical and adult-use markets. It offers a variety of cannabis products such as dried cannabis, pre-rolls, edibles, concentrates, and extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS, and operates adult-use brands, including Spinach. The company incurs an interest expense of $0.00 reflecting its debt servicing obligations. With a reported income before tax of -$17,120,000.00 the company showcases its pre-tax profitability. The total costs and expenses for the company are $196,292,000.00 reflecting its overall spending, while the gross profit ratio is 0.32 indicating the efficiency of the company's production and sales operations. Additionally, the diluted EPS is -$0.02 which accounts for potential share dilution. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia, highlighting its international reach. Cronos Group Inc., founded in 2012, is headquartered in Toronto, Canada. The stock is affordable at $2.62 making it suitable for budget-conscious investors. With a market capitalization of $984,624,435.00 the company is classified as a small-cap player, which often attracts a different demographic of investors. Cronos Group is a key player in the Drug Manufacturers - Specialty & Generic industry, significantly contributing to the overall market landscape. The company's stock enjoys high average trading volume of 1,775,400.00 indicating strong liquidity, which can be attractive for active traders. Furthermore, it belongs to the Healthcare sector, driving innovation and growth in a rapidly evolving market. Overall, Cronos Group Inc. combines accessibility with strong market fundamentals, positioning itself effectively for future development and investor interest.
Is Cronos Group Inc. (CRON) a good investment?
Investing in Cronos Group Inc. (CRON) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
What is Cronos Group Inc. (CRON)'s stock forecast?
Analysts predict Cronos Group Inc. stock to fluctuate between $1.60 (low) and $3.43 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Cronos Group Inc.'s market capitalization?
As of 2026-03-11, Cronos Group Inc.'s market cap is $984,624,435, based on 384,618,920 outstanding shares.
How does Cronos Group Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Cronos Group Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Cronos Group Inc. (CRON) stock?
To buy Cronos Group Inc. (CRON) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CRON. Place an order (Market, Limit, etc.).
What is the best time to invest in Cronos Group Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Cronos Group Inc. perform in the last earnings report?
Revenue: $193,363,000 | EPS: -$0.02 | Growth: -122.27%.
Where can I find Cronos Group Inc.'s investor relations reports?
Visit https://www.thecronosgroup.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Cronos Group Inc.?
You can explore historical data from here
What is the all-time high and low for Cronos Group Inc. stock?
All-time high: $7.56 (2021-08-05) | All-time low: $1.60 (2025-04-08).
What are the key trends affecting Cronos Group Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million ; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million
seekingalpha.com
Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash. CRON's acquisition of CanAdelaar and expansion into Europe and Australia position it for accelerated growth and margin improvement over the next 24-36 months. GrowCo's completed capacity expansion and 70% flower volume increase in 2026 are expected to drive top-line and EBITDA margin gains.
defenseworld.net
Cronos Group Inc. (TSE: CRON - Get Free Report)'s share price traded up 2.5% on Tuesday. The stock traded as high as C$3.68 and last traded at C$3.64. 108,808 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 175,697 shares. The stock had previously closed at C$3.55. Wall
globenewswire.com
Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds
globenewswire.com
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
marijuanastocks.com
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead to profitability. There are different sectors and markets to pay attention to.
globenewswire.com
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos' borderless product strategy, expanding the Company's globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world.
zacks.com
E considers moving ahead with the Cronos gas project off Cyprus, which could supply natural gas to Europe by 2027.
zacks.com
Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 investors.
seekingalpha.com
Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior balance sheet. This superiority is a result of a 2019 investment by Altria of $1.8 billion. CRON has experienced consistent cash burn and deep losses since 2019 as it has built and adapted its operations to the newly legalized adult-use cannabis industry in Canada.
See all news
